Found 8 matching trials
A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates PHASE1 This study aims to assess the safety and effectiveness of four new candidat...
Show More Location
Centre for Clinical Vaccinology and Tropical Medicine
Learn More & Join Trial
Trial to Evaluate L9LS in Healthy Adults PHASE1 Background:
Malaria is a parasitic disease carried by mosquitoes in tropic...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1 PHASE1 This is an open label, multi-centre phase I/IIa sporozoite-challenge trial ...
Show More Location
Wellcome Trust CRF, Southampton General Hospital
Learn More & Join Trial
Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites PHASE1 This study is to assess the safety, tolerability, and biomarkers of protect...
Show More Location
Naval Medical Research Center Clinical Trials Center (CTC)
Learn More & Join Trial
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis PHASE1 The purpose of the study is to determine the safety and tolerability of ID ...
Show More Location
Radboud University Nijmegen Medical Centre
Learn More & Join Trial
Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2 NA This is a single-center, open label study. The primary aim of this project ...
Show More Location
Radboud university medical center
Learn More & Join Trial
Trial to Evaluate CIS43LS in Healthy Adults PHASE1 Background:
People get malaria when they are bitten by an infected mosquit...
Show More Location
University of Maryland Baltimore, Center for Vaccine Development
Learn More & Join Trial
PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults PHASE2 This is an open-label evaluation of the safety, tolerability, immunogenicit...
Show More Location
University of Maryland-Baltimore, Center for Vaccine Development
Learn More & Join Trial